The Effects of Tiopronin on 3-Aminopropanal Level & Neurologic Outcome After Aneurysmal Subarachnoid Hemorrhage

Completed

Phase 2 Results N/A

Summary of Purpose

The purpose of this phase II study is to further assess the safety of tiopronin in aneurysmal subarachnoid hemorrhage(aSAH) patients in order to obtain preliminary data on the efficacy of tiopronin versus placebo in reducing serum and cerebrospinal fluid (CSF) 3AP levels in this patient population. Funding Source - FDA Office of Orphan Products Development

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 15 June 2016.

1 Apr 2010 25 Mar 2010 1 Jul 2012 1 Jul 2013 1 Jun 2016 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
  • Purpose: Treatment
  • Endpoint: Bio-availability Study
  • Intervention: Parallel Assignment

Contacts